Yale scientists seek to protect cancer patients from flu

Yale Cancer Center scientists have created a vaccine strategy to protect cancer patients -- considered to be at the highest risk for developing influenza infections -- against the flu. Read More »

Mexico approves Flublok vaccine

Protein Sciences Corp., the producer of Flublok, recently received approval from Mexico to distribute the company’s Flublok influenza vaccine to the Mexican market. Read More »

New website features Flublok Influenza Vaccine

Protein Sciences recently launched a website dedicated to its Flublock Influenza Vaccine at Read More »

Takeda speeds new treatments for neglected tropical diseases

Takeda Pharmaceutical Company Limited recently announced that it has joined WIPO Re:Search, which is a consortium that is dedicated to speeding the research and development of new vaccines, drugs and diagnostics for neglected tropical diseases, tuberculosis (TB) and malaria. Read More »

CaroGen unveils research for hepatitis B therapeutic vaccine technology

CaroGen Corporation, an emerging vaccine company, recently announced that it has electronically published information about its research for therapeutic vaccine technology, specifically for the hepatitis B virus. Read More »

FDA approves Flublok influenza vaccine for 2015-16

Protein Sciences Corp. recently announced that the U.S. Food and Drug Association (FDA) has approved the company’s Flublok influenza vaccine composition for the 2015-16 flu season. Read More »

Bird flu spreads to farms in 11 states

Health officials have announced that the highly pathogenic strain of bird flu known as H5N2 has affected more than 25 million birds throughout 11 states within the U.S. and it continues to spread. Read More »

Flublok proves more effective than traditional influenza vaccine

Protein Sciences Corporation recently announced that the latest topline data demonstrates that Flublok Quadrivalent, the quadrivalent equivalent of the trivalent Flublok influenza vaccine that the FDA has already approved, is more effective than the traditional influenza vaccine. Read More »

Conn. pathologist creates accurate detection method for Ebola

Sin Hang Lee's method involves a nested RT-PCR method. Read More »

Takeda consolidates US vaccine sites in Boston

Takeda Pharmaceutical Co. Ltd. recently announced that it will begin to consolidate the company’s Vaccine Business Unit (VBU) operations throughout the Boston and Cambridge area. Read More »

Post Holdings updates on avian influenza outbreak

A recent announcement from Post Holdings, Inc., a holding company of consumer packaged goods, revealed information about how the recent outbreak of avian influenza has impacted the company’s egg business. Read More »

Takeda to distribute seasonal flu vaccines in Japan

Takeda Pharmaceutical Co. Ltd. recently announced that it has partnered with the Chemo-Sero-Therapeutic Research Institute to distribute Kaketsuken’s seasonal influenza vaccine throughout Japan. Read More »

Takeda transfers HPV vaccine license to Kaketsuken

Takeda Pharmaceutical Company, Ltd., has recently transferred its license agreement for a vaccine for human papillomavirus (HPV) to Kaketsuken, the Chemo-Sero-Therapeutic Research Institute. Read More »

Oklahoma, South Carolina top latest Walgreens Flu Index

The Walgreens Flu Index, a weekly report that provides state- and market-specific information regarding flu activity, has been released for the period ending Feb. 16. Read More »

Walgreens releases latest flu index report

Walgreens recently released its most recent flu index for the week of Feb. 9. Read More »

Takeda halts DTaP-sIP vaccine development

Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan and Asia, recently announced that it has discontinued the development of TAK-361S vaccine, which was in clinical development Phase 2. Read More »

Walgreens releases most recent data from Flu Index

Walgreens recently released the latest data gathered from its weekly Walgreens Flu Index™ for the week beginning February 2, 2015. Read More »